PSNC monitoring generics shortages as Bristol Labs suspension extended
PSNC has told C+D it will continue to monitor generics shortages “very closely” after Bristol Laboratories had its manufacturing suspension extended.
PSNC has told C+D it will continue to monitor generics shortages “very closely” after Bristol Laboratories had its manufacturing suspension extended.